20
Unimark Remedies Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Lisinopril dihydrate, supported by a 'Suspended by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2004-063 - Rev 04
This Chemical Type CEP, issued on March 11, 2020, remains in force until May 07, 2024, ensuring its reliability within the pharmaceutical industry.
Substance Number 1120 associated with this CEP further emphasizes